- Home
- MIST vs ITIC Comparison
MIST vs ITIC Comparison
Compare MIST & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- ITIC
- Stock Information
- Founded
- MIST 2003
- ITIC 1972
- Country
- MIST Canada
- ITIC United States
- Employees
- MIST N/A
- ITIC N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- ITIC Specialty Insurers
- Sector
- MIST Health Care
- ITIC Finance
- Exchange
- MIST Nasdaq
- ITIC Nasdaq
- Market Cap
- MIST 53.9M
- ITIC 437.8M
- IPO Year
- MIST N/A
- ITIC N/A
- Fundamental
- Price
- MIST $1.16
- ITIC $239.58
- Analyst Decision
- MIST Strong Buy
- ITIC
- Analyst Count
- MIST 2
- ITIC 0
- Target Price
- MIST $9.50
- ITIC N/A
- AVG Volume (30 Days)
- MIST 1.6M
- ITIC 10.6K
- Earning Date
- MIST 05-20-2025
- ITIC 05-08-2025
- Dividend Yield
- MIST N/A
- ITIC 6.56%
- EPS Growth
- MIST N/A
- ITIC 18.56
- EPS
- MIST N/A
- ITIC 15.69
- Revenue
- MIST N/A
- ITIC $261,183,000.00
- Revenue This Year
- MIST N/A
- ITIC N/A
- Revenue Next Year
- MIST N/A
- ITIC N/A
- P/E Ratio
- MIST N/A
- ITIC $14.55
- Revenue Growth
- MIST N/A
- ITIC 15.26
- 52 Week Low
- MIST $0.63
- ITIC $146.41
- 52 Week High
- MIST $2.75
- ITIC $290.40
- Technical
- Relative Strength Index (RSI)
- MIST 46.48
- ITIC 56.40
- Support Level
- MIST $1.28
- ITIC $237.00
- Resistance Level
- MIST $1.32
- ITIC $244.00
- Average True Range (ATR)
- MIST 0.12
- ITIC 4.68
- MACD
- MIST 0.03
- ITIC 1.34
- Stochastic Oscillator
- MIST 38.80
- ITIC 78.68
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.